Search clinical trials for: Agalsidase Beta

Total 6043 results

National Institute of Mental Health (NIMH)

Recruiting

Effects of an ER Beta Agonist (Lilly Compound LY500307) on Estradiol-Withdrawal-Induced Mood Symptoms in Women With Past Perimenopausal Depression

Perimenopause-Related Depression

United States
BIO-CAT, Inc.
Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

Completed

Safety and Tolerability Trial of Microbial Inulinase

Gastrointestinal Health | Digestive Health

Canada
Fakultas Kedokteran Universitas Indonesia

Unknown

Beta-1,3/1,6-D-Glucan Ganoderma Lucidum on Ulcerative Colitis

Ulcerative Colitis

Indonesia
Kemin Foods LC
KGK Science Inc.

Completed

Ability of a Euglena Beta Glucan Supplementation to Augment Immune Function

Symptoms Flu | Symptoms Cold

Canada
Hoffmann-La Roche

Completed

An Observational Study of Methoxy Polyethylene Glycol-epoetin Beta in Participants With a Kidney Transplant

Anemia, Kidney Transplantation

Germany
Merck KGaA, Darmstadt, Germany
Merck Serono S.P.A., Italy

Completed

Dietary Supplement of Curcumin in Subjects With Active Relapsing Multiple Sclerosis Treated With Subcutaneous Interferon Beta 1a (CONTAIN)

Multiple Sclerosis

Italy
Children's Hospital of Philadelphia

Recruiting

Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies (AB-CliniMACs)

Lymphoma | Leukemia | Myelodysplasia

United States
Hoffmann-La Roche

Completed

COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.

Anemia

Australia
PATH
Walter Reed Army Institute of Research (WRAIR); Kenya Medical Research Institute

Completed

Evaluation of the MBio Combined Syphilis/HIV Point-of-Care Diagnostic Test (MBIO)

HIV | Syphilis

Kenya
Biogen

Completed

A Single-Dose, Pharmacokinetic/Pharmacodynamic (PK/PD), & Safety Study of BIIB017 in Participants With Renal Impairment & Healthy Volunteers

Healthy | Renal Insufficiency
Chonbuk National University Hospital

Completed

Efficacy and Safety of Fermented Barley on Decrement of Body Fat in Obese Subjects

Overweight; Hyperlipidemia

Korea, Republic of
Nestlé
University Hospital Inselspital, Berne; University of Bern

Completed

Effect of β-alanine Supplementation on Muscle Carnosine (LitmusMagnet)

Healthy

Switzerland
Aretaieion University Hospital

Recruiting

The Impact of Esmolol Administration on Postoperative Recovery (esmolol)

Pain, Postoperative | Analgesia | Pain, Acute | Nociceptive Pain | Inguinal Hernia Repair | Pain, Chronic Post-Surgical | Esmolol

Greece
Indiana University
Office of Naval Research (ONR)

Completed

MIrabegron and Physiological Function in Cold Environments

Resting Energy Expenditure | Brown Adipose Tissue | Thermogenesis

United States
Indiana University
Office of Naval Research (ONR)

Completed

Mirabegron and Physiological Function in Cold Environments

Resting Energy Expenditure | Brown Adipose Tissue | Thermogenesis

United States
University of Manitoba
Canadian Institutes of Health Research (CIHR); Agriculture and Agri-Food Canada

Completed

Canola Oil, Fibre and DHA Enhanced Clinical Trial

Metabolic Syndrome

Canada
Korea University Anam Hospital

Active, not recruiting

Effect of Different Antihypertensive Drugs on Central Blood Pressure

Hypertension

Korea, Republic of
Astellas Pharma China, Inc.

Completed

A Study to Investigate the Effect of Food With Mirabegron in Healthy Chinese Participants

Pharmacokinetics of Mirabegron | Food Effect | Healthy Chinese Subjects

China
Swiss Group for Clinical Cancer Research

Completed

Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutation

Primary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Myeloproliferative Neoplasm

Switzerland
CHU de Quebec-Universite Laval

Completed

Pilot Study of Mirabegron in Pediatric Patients With Overactive Bladder (Mirabegron)

Overactive Bladder | Urinary Incontinence
Mercy Research
Forest Laboratories

Completed

Effects of Nebivolol on Exercise Tolerance and Left Ventricular Systolic and Diastolic Function

Hypertension

United States
Astellas Pharma Inc

Completed

A Study of YM178 in Patients With Symptomatic Overactive Bladder

Urinary Bladder, Overactive

Japan
AOP Orphan Pharmaceuticals AG

Completed

A Short Term Pharmacokinetic, Pharmacodynamic and Tolerability Study to Compare AOP200704 vs. Esmolol

Healthy Volunteers | Pharmacokinetics/Dynamics Study

Czech Republic
Mylan Bertek Pharmaceuticals

Completed

A Study of the Efficacy and Safety of Nebivolol Added to Existing Antihypertensive Treatment in Patients With Hypertension

Hypertension

United States
OHSU Knight Cancer Institute
Oregon Health and Science University; Kuni Foundation

Recruiting

Atorvastatin for Preventing Disease Metastasis in Patients With Resected High-Risk Stage IIA Melanoma

Clinical Stage IIA Cutaneous Melanoma AJCC v8

United States
First Affiliated Hospital of Zhejiang University

Recruiting

Clinical Study on Monitoring the Plasma Concentration of Ceftazidime-Avibactam in Critically Ill Patients

Severe Sepsis

China
Assiut University

Not yet recruiting

Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Risk of COVID_19

COVID-19 Pneumonia
Assistance Publique - Hôpitaux de Paris
Groupe Hospitalier Pitie-Salpetriere

Completed

Beta Blocker Interruption After Uncomplicated Myocardial Infarction (AβYSS)

Myocardial Infarction

France
Johns Hopkins University
Astellas Pharma US, Inc.

Completed

Mirabegron For Erectile Dysfunction

Overactive Bladder | Urinary Incontinence | Erectile Dysfunction

United States
State University of New York at Buffalo
Astellas Pharma Inc

Withdrawn

Mirabegron for the Treatment of Pain Motivated Urinary Frequency and Urgency in Women

Urinary Frequency/Urgency | Bladder Pain Syndrome | Bladder Irritable

United States
Hospital de Base

Unknown

The Effects of Esmolol on the Hemodynamic Response to Orotracheal Extubation

Hemodynamic Instability | Beta Blocker

Brazil
Mansoura University

Unknown

Mirabegron for Treatment of Erectile Dysfunction in Patients With LUTS Secondry to BPH: A Randomized Study

Prostatic Neoplasms | Erectile Dysfunction | BPH | Prostate Hyperplasia | Erectile Abnormalities

Egypt
M.D. Anderson Cancer Center

Completed

Mesenchymal Stem Cells (MSC) for Ovarian Cancer

Ovarian Cancer

United States
Fundación Centro Nacional de Investigaciones Cardiovasculares...
Hospital Clinic of Barcelona; Fundació Institut de Recerca de l'Hospital de... and other collaborators

Unknown

Beta3 Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure (SPHERE-HF)

Heart Failure | Pulmonary Hypertension | Mirabegron | Pulmonary Vascular Resistance Abnormality
Karolinska Institutet

Completed

Cardiovascular Morbidity During Treatment of Overactive Bladder With B3 Agonists

Overactive Bladder

Sweden
Rempex Pharmaceuticals (a wholly owned subsidiary...

Completed

Safety Study of Intravenous Biapenem (RPX2003) and RPX7009 Given Alone and in Combination

Bacterial Infections | Healthy Volunteers

Australia
Astellas Pharma Inc

Completed

A Study to Evaluate How Mirabegron Enters and Leaves the Bloodstream According to Age and Sex

Healthy Volunteers | Pharmacokinetics of Mirabegron

France
Astellas Pharma China, Inc.

Completed

Study to Assess the Safety and Plasma Concentration of YM178 OCAS Tablet (Mirabegron) in Healthy Chinese Volunteers

Healthy Chinese Volunteers

China
Biogen

Completed

A Multiple-Dose, Open-Label, Phase 1, Pharmacokinetic, Pharmacodynamic, and Safety Study of Avonex® in Chinese Healthy Volunteer Subjects

Healthy

China
Taipei Veterans General Hospital, Taiwan

Recruiting

Sequencing and Combination of Mirabegron and TTNS in Overactive Bladder Syndrome: a Multicenter, Randomized, Open-label, Crossover Trial

Overactive Bladder Syndrome

Taiwan
Purdue University

Completed

Comparing the Gastric Transit of Commercial Milk and A2 Milk

Lactose Intolerance, Adult Type

United States
Southern Illinois University
Astellas Scientific & Medical Affairs, Inc.; Sisters of the Third Order of...

Terminated

Myrbetriq™ (Mirabegron) to Reduce Pain and Discomfort Following Ureteral Stent Placement

Pain | Urinary Bladder, Overactive | Lower Urinary Tract Symptoms

United States
University of Florida
National Institute of General Medical Sciences (NIGMS)

Terminated

Improving Treatment Personalization of Pulmonary Hypertension Associated With Diastolic Heart Failure

Pulmonary Hypertension | Heart Failure With Preserved Ejection Fraction | Diastolic Heart Failure

United States
Benha University

Completed

Dose Esmolol Infusion Have an Adjuvant Effect to TAP Block for Pain Control in Laparoscopic Cholecystectomy.

Postoperative Pain

Egypt
The University of Texas Health Science Center at...

Completed

Treatment of Spinal Cord Injury Patients for Neurogenic Bladder: Anticholinergic Agent vs. Mirabegron (SCIMYR)

Cognitive Change | Spinal Cord Injuries | Neurogenic Bladder

United States
Loyola University
Astellas Pharma US, Inc.

Completed

Mirabegron and Urinary Urgency Incontinence

Overactive Bladder

United States
Buddhist Tzu Chi General Hospital

Unknown

Therapeutic Efficacy and Safety of Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan

Overactive Bladder Syndrome

Taiwan
Biocad

Completed

Pharmacokinetics and Pharmacodynamics Study of BCD-033 Compared to Rebif® in Healthy Volunteers

Healthy

Russian Federation
Astellas Pharma Inc

Completed

A Long-term Study of YM178 in Symptomatic Overactive Bladder Patients

Urinary Bladder, Overactive

Japan
Astellas Pharma Inc

Completed

Specified Drug Use-results Survey of Betanis Tablets for Patients With Coexisting Cardiovascular Disease

Overactive Bladder | Cardiovascular Disease

Japan

Search clinical trials for: Agalsidase Beta

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in France

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations